Skip to main content
NCCN-protocol care · 96.9% 1-yr breast cancer survival · ArogyaSri, CGHS & cashless insurance accepted · Free second opinion
1800 202 8726
Pancreatic Cancer · Types, Location & Resectability · Reviewed by CION Oncologists

Resectable pancreatic cancer — what the word actually means

Resectable means the tumour can be removed completely — a judgement about vessels and anatomy, not about size or stage. This page explains what the scan is being read for, how the four categories differ, and why an operation is only half of the treatment plan.

  • It is about vessels, not size — whether the tumour is clear of the arteries and veins behind the pancreas.
  • Resectable is not a stage — the category, not the stage number, is what the plan is built on.
  • Surgery is coordinated, not in-house — partner HPB and GI surgeons operate; CION holds everything around it.
  • Chemotherapy is part of the cure attempt — before the operation, after it, or both — never an optional extra.
4.8 · 800+ Google reviews · 15,000+ patients treated
Same-week appointments

Told it is operable? Get the plan explained first.

₹950   Today: FREE  ·  Including free written second opinion

Tumour board reviews every case
45-minute consultation, plain answers
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
35+
Centres Across
Telangana & AP
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)
Start here

What “Resectable” Actually Means

Someone has handed you a scan report with the word resectable on it and moved on to the next sentence. It is the most important word on that page, and it deserves a proper explanation. Resectable pancreatic cancer means the tumour can be lifted out completely by an operation, with a rim of normal tissue around it. It does not mean the tumour is tiny. It does not mean you caught it in time. And it does not mean surgery is the only treatment you will need.

The word is about anatomy, not size. Directly behind the pancreas run the vessels that feed the liver, the bowel and the spleen — the coeliac axis, the common hepatic artery, the superior mesenteric artery, and the superior mesenteric and portal veins. A tumour that sits clear of those vessels can be removed. A tumour that has grown around one of them cannot be removed cleanly, however small it looks on the picture. That single relationship, tumour to vessel, is what the radiologist is reporting on, and it is what the word resectable is describing.

You may also hear this called operable pancreatic cancer, or be told you have a removable pancreatic tumour. They point at the same finding, though the word operable quietly carries a second question: whether you are well enough for a long operation and the recovery that follows it. A tumour can be technically removable while the person in front of us is not yet fit for theatre. That gap is often closeable — with nutrition, enzyme support, better diabetes control and a few weeks — and it is worth naming rather than leaving as an unspoken doubt.

Resectable is also not a stage. Staging describes tumour size, lymph nodes and distant spread, and gives you a number. Resectability describes vessels, and gives you a plan. The two often line up, but not always, and when they disagree it is the resectability category that decides what happens first. NCCN guidance frames localised pancreatic cancer this way for exactly that reason: the category, rather than the stage label, is what the treatment decision hangs on. If you want the wider picture around this, the complete guide to pancreatic cancer sets out how diagnosis, staging and treatment fit together.

One more thing to say plainly before anything else. Resectable does not mean surgery alone. Removing the tumour completely is the part of treatment that offers a genuine chance of cure, but on its own it is only half the attempt. Chemotherapy after surgery is part of the same plan, not an optional add-on, and in some cases chemotherapy is given first instead. Anyone who tells you the operation is the whole of the treatment has told you half the story.

Did you know? NCCN guidance sorts localised pancreatic cancer into defined resectability categories — resectable, borderline resectable and locally advanced — using the tumour's relationship to named vessels: the coeliac axis, the common hepatic artery and the superior mesenteric artery, and the superior mesenteric and portal veins. The same guidance recommends that the assessment be made on a dedicated pancreatic-protocol contrast CT rather than an ordinary abdominal scan, that it is best done before a biliary stent is placed because a stent makes the anatomy harder to read, and that every case is reviewed by a multidisciplinary team before treatment starts. If you are told your tumour is resectable on the strength of a routine scan alone, asking for a pancreatic-protocol study is a reasonable and often useful question.
What is actually being looked at

What the Scan Is Being Read For

A radiologist reporting a pancreatic-protocol CT is answering a short list of specific questions. These are the ones that decide the category.

The arteries

Whether the tumour touches an artery

Contact with the coeliac axis, the common hepatic artery or the superior mesenteric artery is the finding that most often moves a tumour out of the resectable group. An artery cannot be rebuilt as readily as a vein.

The veins

Whether the portal or mesenteric vein is involved

Limited vein contact does not automatically rule surgery out; a short segment of vein can be removed and reconstructed. A vein that is encased over a long stretch, or already blocked, usually does.

Distant spread

Whether anything has travelled

The liver, the lining of the abdomen and the chest are checked deliberately. A single deposit outside the pancreas changes the category and the plan, whatever the local anatomy looks like.

Lymph nodes

Which nodes look involved, and where they sit

Nodes immediately around the pancreas are removed with the specimen as a matter of course. Nodes well outside the field of the operation are looked for specifically, because they mean something different.

Location

Head, body or tail of the pancreas

Where the tumour sits decides which operation is being discussed. A tumour in the head points to the Whipple procedure; body or tail usually means removing the left side of the pancreas.

The scan itself

Whether the study can answer the question

An ordinary abdominal CT often cannot. The categories are defined on a pancreatic-protocol study with proper contrast timing, which is why an outside scan is sometimes repeated rather than simply accepted.

Where your report sits

Resectable, Borderline, Locally Advanced, Metastatic

Four categories, one axis: how much of the tumour's edge is tangled with a vessel, and whether anything has spread. This is the table worth finding yourself on.

The four pancreatic cancer resectability categories, what the scan shows in each, and what usually happens first
Category What the scan shows What usually happens first
Resectable Clear tissue planes around the arteries, no or only slight vein contact, and nothing outside the pancreas. Surgery, followed by chemotherapy — or, in selected cases, chemotherapy first and then surgery.
Borderline resectable Limited artery contact, or vein involvement that a surgeon could remove and reconstruct. Systemic treatment first, then the scan is repeated and the decision made again — what happens with borderline resectable disease.
Locally advanced The tumour encases a major artery, but there is still no spread beyond the region. Systemic treatment, with chemoradiation or SBRT in selected cases; surgery reconsidered only if the picture changes markedly.
Metastatic Disease in the liver, the lining of the abdomen or the lungs. Systemic treatment aimed at control, symptoms and quality of life rather than removal.

These categories move. A borderline tumour that responds well to treatment can be reassessed and operated on; a resectable tumour can be reclassified if a new finding appears before theatre. The category on today's report is a starting point, not a verdict. If you would like your treatment options in Hyderabad set out against your own scan, book a free consultation or call 1800 202 8726.

Take this to your appointment

What to Ask Before the Operation Is Booked

Written down in the order they are most useful. None of these is a difficult or awkward question, and every one of them changes what you understand about the plan.

  • Which category am I in, and what was that decided on? Ask whether the assessment came from a pancreatic-protocol CT or from a general scan. It is the difference between a firm answer and a provisional one.
  • Is there any contact with an artery or a vein? Ask for it in plain words. Vein contact and artery contact carry very different weight, and being told simply that the scan is “concerning” tells you nothing you can act on.
  • Has my case been through a multidisciplinary tumour board? One opinion is not the same as a team decision, and NCCN guidance expects the team review to happen before treatment starts, not after it.
  • Which operation are we actually talking about? The answer depends on where the tumour sits, and it changes the recovery entirely — what a Whipple procedure involves is worth reading before you consent to one.
  • Is chemotherapy planned before surgery, after it, or both? Have the whole sequence explained at the start rather than discovering the next stage after you have recovered from the first.
  • What would move me out of the resectable group, and what would move me back in? If the answer is borderline rather than resectable, ask what a good response to treatment would allow — borderline resectable pancreatic cancer explains how that reassessment works.
  • Who performs the operation, where, and who invoices me for it? A pancreatic pathway usually involves more than one institution. Ask early so the billing is never a surprise later.

If you have a report with a category on it and no idea what it means for you, bring it in. We will read it with you and say plainly what it does and does not settle. Book a free consultation or call 1800 202 8726.

A Report That Says Resectable, and No One Has Explained It?

Bring the scan discs. We will read them with you and say plainly which category you are in.

or
Call 1800 202 8726
12+ Centres in Hyderabad · Pick yours

CION cancer care is closer than you think.

We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.

Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.

Help me pick the right centre
Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

The Operation Is Coordinated. The Plan Around It Is Ours.

Staging, tumour board, chemotherapy, nutrition and follow-up are delivered by CION across 35+ centres.

Book Free Consultation Call 1800 202 8726
What actually happens

How the Resectability Decision Is Actually Made

The order matters. Each step either confirms the category or changes it, and the plan is only fixed once all of them have been answered.

  1. A pancreatic-protocol CT, read for vessels

    Not a routine abdominal scan. The study is timed to show the arteries and the veins separately, and it is reported specifically against the resectability criteria rather than as a general abdominal report.

    Ordered and reported in-house at CION
  2. Tissue diagnosis, where it is needed

    A sample is usually taken by endoscopic ultrasound with a fine needle. For a clearly resectable tumour going straight to theatre, a biopsy is not always required first — that is a decision for the team, not a default.

    Endoscopic ultrasound and biopsy coordinated with specialist endoscopy partners
  3. Baseline CA 19-9 and bloods

    A single reading tells you little; the trend tells you a great deal. Taking the baseline before treatment starts is what makes the later readings interpretable at all. Liver function and nutritional bloods are checked at the same time.

    In-house at CION
  4. Staging laparoscopy in selected cases

    Where the scan is reassuring but something else is not — a rising marker, an equivocal finding — a short look inside the abdomen before the main operation can spot small deposits that imaging misses.

    Coordinated with specialist HPB / GI surgical partners
  5. The case goes to tumour board

    Medical oncology, radiation oncology and the partner surgical team look at the same images together and agree a category and a sequence. Disagreement at this table is useful; it is far better resolved here than in theatre.

    Tumour board at CION, with partner HPB / GI surgeons
  6. The plan is written down, with its decision points

    Which treatment first, when the scan is repeated, and what result would change the plan — agreed in advance. Pancreatic cancer treatment in Hyderabad sets out the options this plan is drawn from.

    Free 45-minute consultation at CION
Plainly stated

What CION Delivers, and What Is Coordinated

Saying this early saves an awkward conversation later. Your first consultation is free and lasts 45 minutes, and it is a genuine review of your scans and reports rather than a booking appointment. Bring the imaging discs, not only the typed report, because the pictures answer the resectability question and the summary often does not.

Delivered in-house at CION, across 35+ centres in Telangana and Andhra Pradesh: the ordering and reporting of pancreatic-protocol CT, MRI and MRCP, CA 19-9 and routine bloods; the tumour-board review and the resectability decision itself; medical oncology — chemotherapy before surgery, after surgery and for advanced disease, PARP-inhibitor-class maintenance where an inherited BRCA change is found, and immune checkpoint treatment where the tumour is mismatch-repair deficient; radiation, chemoradiation and SBRT; genetic counselling; nutrition and pancreatic enzyme replacement; pain relief, psycho-oncology and supportive care; and survivorship follow-up after the operation.

Coordinated with specialist HPB, gastroenterology and endoscopy partner centres, and may be billed there: every pancreatic operation, including the Whipple procedure and removal of the body and tail; staging laparoscopy; endoscopic ultrasound with biopsy; ERCP and biliary or duodenal stenting; coeliac plexus block for pain; PET-CT and DOTATATE PET; and peptide receptor radionuclide therapy. CION does not perform pancreatic surgery in-house. We arrange it, we sit at the table where the decision is made, and we tell you in advance which hospital you will be operated in and who will invoice you for that part. We do not describe a partner's theatre list as our own, because it is not.

That split is not a hedge. It is the reason the plan holds together: the operation is done by surgeons who do a high number of them, while the staging, the systemic treatment, the nutrition and the follow-up stay with one team that knows your case from the first scan onwards.

The second half of the plan

Resectable Is the Beginning of Treatment, Not the End

The pathology report that comes back after the operation is the most informative document in the whole pathway, and it is the one people are least often walked through. It tells you whether the margins were microscopically clear, how many of the removed nodes were involved, the grade of the tumour and whether it had grown along nerves. None of that is visible on any scan beforehand, which is why a plan is always provisional until the specimen has been examined.

That report then shapes what follows. Chemotherapy after surgery is a standard part of the cure attempt for pancreatic adenocarcinoma, not an insurance policy bolted on afterwards, and it is delivered at CION. The timing matters more than most people are told: it is usually started once you have recovered enough to get through it, and recovering well enough to start is itself a treatment goal in the weeks after theatre.

Recovery is where our supportive work does most of its good. After a pancreatic resection, digestion changes. Many people need pancreatic enzyme replacement with every meal, and some develop diabetes because insulin-producing tissue has been removed. Weight loss in the first weeks is common and is not a sign that something has gone wrong, but it does need managing rather than tolerating — a person who is eating and gaining strength tolerates chemotherapy far better than one who is not.

And be prepared for the possibility that the plan changes at the last moment. Occasionally a surgeon opens the abdomen, finds disease that no scan showed, and does not proceed with the resection. That is a decision made in your interest, not a failure of the team or of you. Where that happens, treatment moves to the systemic side of the plan the same week, and nothing about your care stops.

If you have been told your tumour is removable and want the whole sequence — scan, tumour board, operation, chemotherapy, follow-up — explained once, properly, in one sitting, that is what the first appointment is for. Book a free consultation or call 1800 202 8726.

A Report That Says Resectable, and No One Has Explained It?

Bring the scan discs. We will read them with you and say plainly which category you are in.

or
Call 1800 202 8726
Take the next step

Understand the Category Before You Consent to Anything

One unhurried appointment turns a word on a report into a plan you can follow. We walk this journey with you.

Book Free Consultation Call 1800 202 8726
Real Stories. Real Voices.

15,000+ patients chose CION. Hear from them directly.

These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.

4.8★800+ Google reviews
50+video testimonials
15,000+patients treated

Successful Chemotherapy Done by Dr. C Raghavendra Reddy

Watch video →

Surgery, Chemo & Radiation Done by Dr. Imaduddin, Dr. Vinay, Dr. Owais, Dr. Kirti

Watch video →

Successful Radical Thymectomy Done by Dr. Mohammed Imaduddin & Dr. Vinay Mamidala

Watch video →

Successful Surgery Done by Dr. Rajender Byshetty

Watch video →

Successful Chemo & Surgery Done by Dr. Imad, Dr. Vinay, Dr. Owais & Dr. Raghavendra

Watch video →

Successful Chemo & Surgery Done by Dr. Imad, Dr. Vinay, Dr. Owais & Dr. Raghavendra

Watch video →

Successful Chemo & Radiation Done by Dr. Owais Mohammed & Dr. Kirti Ranjan Mohanty

Watch video →

Successful Breast Cancer Surgery Done by Dr. Imaduddin Mohammed & Dr. Vinay Mamidala

Watch video →

Successful Chemotherapy Done by Dr. Bharati Devi Gorantla

Watch video →

Successful Chemo & Surgery Done by Dr. Owais Mohammed & Dr. Imaduddin Mohammed

Watch video →

Successful Chemotherapy Done by Dr. Gundu Naresh

Watch video →

Successful Bone Marrow Transplantation - Neuroblastoma

Watch video →

Successful Surgery & Chemo - Carcinoma of Caecum

Watch video →

Successful Oral chemotherapy & mastectomy surgery

Watch video →

Successful Oral chemotherapy & mastectomy surgery

Watch video →

Successful Chemotherapy

Watch video →

Successful Surgery by Dr. Mohammed Imaduddin

Watch video →

Successful Bone Marrow Transplantation

Watch video →

Successful Oral chemotherapy & mastectomy surgery

Watch video →

Successful Oral chemotherapy & mastectomy surgery

Watch video →

Successful Chemotherapy

Watch video →

Successful Buccal Mucosa Surgery

Watch video →

Successful Complex Surgery Mandibulectomy Reconstruction

Watch video →
Common questions

Resectable pancreatic cancer — your questions answered

What does resectable pancreatic cancer actually mean?
It means the tumour can be removed completely by an operation, with a rim of normal tissue around it. The judgement is anatomical rather than a matter of size. Directly behind the pancreas run the coeliac axis, the common hepatic artery, the superior mesenteric artery and the superior mesenteric and portal veins. A tumour sitting clear of those vessels can be lifted out; one that has grown around an artery cannot be removed cleanly, however small it appears. So resectable describes a relationship between the tumour and the vessels, reported on a pancreatic-protocol CT scan. It is a category that guides the plan, not a promise about the outcome, and it can change if the scan is repeated or a new finding appears.
Is resectable the same as early stage pancreatic cancer?
No, although the two often go together. Staging describes the size of the tumour, whether lymph nodes are involved and whether disease has spread to distant organs, and it gives you a number. Resectability describes the tumour's relationship to the arteries and veins behind the pancreas, and it gives you a plan. A tumour can be modest in size and still be wrapped around an artery, which makes it unresectable despite a reassuring-sounding stage. The reverse happens too. NCCN guidance frames localised pancreatic cancer by resectability category precisely because that is what treatment decisions hang on. If your report gives a stage but no category, that is a fair thing to ask about.
Does resectable mean I will definitely have surgery?
Not automatically. Resectable describes the tumour; whether an operation goes ahead also depends on you. A pancreatic resection is a long operation with a demanding recovery, so your general fitness, heart and lung function, nutrition and diabetes control are all assessed before it is booked. Where someone is not yet strong enough, the answer is usually to spend a few weeks improving that rather than abandoning the plan. Sometimes the team recommends chemotherapy first even for a clearly resectable tumour, to treat disease too small to see and to test how the cancer behaves. And occasionally a surgeon finds disease at operation that no scan showed and does not proceed. That is a decision made in your interest.
What is the difference between resectable and borderline resectable?
The difference is how much the tumour is tangled with a vessel. In resectable disease there are clear tissue planes around the arteries and no more than slight contact with the veins. In borderline resectable disease there is limited contact with an artery, or vein involvement that a surgeon could remove and reconstruct, so an operation is possible but a clear margin is not confidently predictable. The usual response to borderline disease is systemic treatment first, then repeat imaging and a fresh decision, rather than proceeding straight to theatre. Borderline is not a refusal of surgery. It is a different running order, and a good response to treatment can move the answer.
If the tumour is removed completely, do I still need chemotherapy?
In almost all cases of pancreatic adenocarcinoma, yes. Even a technically complete removal with clear margins cannot address cells that have already left the pancreas and are too small to see on any scan or find in the specimen. Chemotherapy after surgery is a standard part of the cure attempt rather than an optional extra, and the evidence for giving it is one of the more settled points in pancreatic cancer care. In some plans chemotherapy is given before the operation instead, or both before and after. The sequence is decided at tumour board and should be explained to you at the start, not discovered stage by stage as you go along.
Can a resectable tumour become unresectable while I wait?
It can, which is why the interval between the decision and the operation is kept as short as is safely possible. This is one of the few parts of the pathway where delay genuinely costs something. If a scan is more than a few weeks old when surgery is being planned, it is often repeated so the anatomy being operated on is current. That said, being anxious about a wait of days is understandable but rarely warranted, and rushing to theatre without a proper pancreatic-protocol scan, a tumour-board review and adequate nutrition tends to produce a worse operation. Ask the team what the planned date is and what would bring it forward.
Does surgery hurt more if I am older or diabetic?
Age by itself is not a barrier; physiological fitness matters far more than the number of years. What is assessed is heart and lung reserve, muscle mass, nutritional state, kidney function and how well any diabetes is controlled. Poorly controlled blood sugar and significant weight loss both make recovery harder and are worth correcting before theatre rather than after it. Pancreatic enzyme replacement, a dietitian-led plan and better glucose control in the weeks beforehand measurably improve how people get through the operation and the chemotherapy that follows. Where someone is genuinely too frail for a resection, systemic treatment and good supportive care remain fully available and are not a lesser plan.
Does CION perform the operation, and what happens at my first visit?
CION does not perform pancreatic surgery in-house. Every pancreatic resection, along with staging laparoscopy, endoscopic ultrasound and biopsy, ERCP and stenting, is coordinated with specialist hepatobiliary, gastroenterology and endoscopy partner centres and may be billed there. What we deliver ourselves, across 35+ centres, is the imaging and its reporting, CA 19-9 and bloods, the tumour-board resectability decision, chemotherapy before and after surgery, radiation and SBRT, genetic counselling, nutrition and enzyme support, pain and psycho-oncology care and long-term follow-up. The first appointment is free and lasts 45 minutes. Bring your scan discs, any reports and your medication list, and we will tell you plainly which category you are in and what comes next.

Medical disclaimer: This page explains what resectability means in pancreatic cancer and how the category is decided, and is reviewed by a CION medical oncologist with reference to NCCN guidance on pancreatic adenocarcinoma. It is general information and not a surgical opinion; whether an operation is appropriate for you depends on your own imaging, fitness and pathology and must be decided with your treating team. Pancreatic-protocol CT, MRI and MRCP ordering and reporting, CA 19-9 and bloods, tumour-board review and the resectability decision, chemotherapy before and after surgery, radiation, chemoradiation and SBRT, genetic counselling, nutrition and pancreatic enzyme (PERT) support, pain, psycho-oncology and supportive care and survivorship follow-up are delivered by CION. Every pancreatic resection including the Whipple procedure and distal pancreatectomy, staging laparoscopy, endoscopic ultrasound and biopsy, ERCP and biliary or duodenal stenting, coeliac plexus block, PET-CT and DOTATATE PET and peptide receptor radionuclide therapy are coordinated with specialist hepatobiliary, gastroenterology, endoscopy and nuclear medicine partner centres and may be billed there.

Call now Book free consultation